Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:37 AM UTC
| NCT Number | NCT06463587 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 264 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 18, 2026: Clinical trial NCT06463587 is currently recruiting participants. This phase3 study for myasthenia gravis is actively seeking new participants at 21 locations across the United States. The study is sponsored by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06463587 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06463587 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.